FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Kruse William R
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/24/2019 

3. Issuer Name and Ticker or Trading Symbol

PreCheck Health Services, Inc. [HLTY]
(Last)        (First)        (Middle)

1340 S. MAIN ST., SUITE 300
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

GRAPEVINE, TX 76051      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
1/7/2020 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common stock, par value $0.0001 per share 1621701 D  
Common stock, par value $0.0001 per share 232820 I Jointly with spouse 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
(1) (1) (1) (1)(1) (1) (1) (1)D  
common stock purchase warrant 4/2/2019 4/2/2022 Common stock 125000 $1.00 D  

Explanation of Responses:
(1) On March 20, 2018, the Company issued to Mr. Kruse for $75,000 a convertible note for $80,250 and warrants to purchase 75,000 shares of common stock at $1.20 per share, subject to adjustment. On September 30, 2018, the Company entered into a note amendment with the note settlement amount amended to $90,000 and note expiry date extended to March 30, 2019. The Company and Mr. Kruse entered into extension agreements, most recently on January 6, 2020 extending to June 20, 2020, the date on which the note is to be paid. Pursuant to the extension agreement, Mr. Kruse agreed not to convert the note or exercise the warrant prior to June 30, 2020, to sell the Note to the Company for $90,000 and to either accept $12,500 or 37,500 shares in exchange for the warrant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Kruse William R
1340 S. MAIN ST.
SUITE 300
GRAPEVINE, TX 76051

X


Signatures
/s/ William R. Kruse1/17/2020
**Signature of Reporting PersonDate